TM
MX icon

Thrax Management’s Magnachip Semiconductor MX Stock Holding History

Thrax Management’s Portfolio MX Stock Details MX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-33,929
Closed -$179K – 124
2015
Q4 		$179K Buy
+33,929
New +$192K 0.04% 82

Other funds holding MX

LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
PLP
Pleasant Lake Partners Rincon, Puerto Rico $7.91M AUM 5.74% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Thrax Management's MX Position: Q1 2016 in Review

Thrax Management sold out of Magnachip Semiconductor (MX) in Q1 2016, closing a stake of 33,929 shares — an estimated $179K sold.

Thrax Management first reported a position in MX in Q4 2015 and held it in 1 quarter. The position peaked at $179K in Q4 2015. 52 funds tracked by Wall St. Rank hold MX as of Q1 2016.

  • Thrax Management reported no remaining Magnachip Semiconductor position as of Q1 2016 after selling out during the quarter.
  • Thrax Management sold 33,929 Magnachip Semiconductor shares in Q1 2016, an estimated $179K.
  • Thrax Management first reported a position in Magnachip Semiconductor in Q4 2015 and held it in 1 quarter.
  • Thrax Management's Magnachip Semiconductor position peaked at $179K in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Magnachip Semiconductor as of Q1 2016.

Based on Thrax Management's 13F filing for Q1 2016, filed 16 May 2016.